Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Acumen Pharmaceuticals FY21 EPS $(5.02) Up From $(17.48) YoY

Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(5.02) per share. This is a 71.28 percent increase over losses of $(17.48) per share from the same period last year.
byBenzinga Newsdesk
March 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(5.02) per share. This is a 71.28 percent increase over losses of $(17.48) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Preview: Vail Resorts

By Benzinga Insights
Today, 7:56 AM
Vail Resorts (NYSE:MTN) is set to give its latest quarterly earnings report on Thursday, 2022-06-09. Here's what investors need to know before the announcement. Analysts estimate that Vail Resorts will report an earnings per share (EPS) of $9.06.

MTN